The IRMA Community
Newsletters
Research IRM
Click a keyword to search titles using our InfoSci-OnDemand powered search:
|
Enterprise Risk Management: A Case Study in the Pharmaceutical Industry
Abstract
How a company successfully implements an Enterprise Risk Management (ERM) program, to identify and manage potential risks, can mean the difference between financial freedom and financial despair. The Committee of Sponsoring Organizations (COSO) guidelines, a voluntary private-sector organization in the United States, has developed internal control guidelines to provide guidance to executive management and governance entities on critical aspects of organizational governance, business ethics, internal control, fraud, and financial reporting. This chapter will discuss an approach to build an ERM implementation plan within a pharmaceutical company by outlining the responsibilities and influences of industry participants, sales forces, middle-management and senior leadership and the ways in which they focus on monitoring and developing the risk mitigation process. The influences of technologies are integrated and new directions, such as e-media and e-detailing (Virtual Sales Representatives) are also explored.
Related Content
|
Emrah Arğın.
© 2022.
16 pages.
|
|
Ebru Gülbuğ Erol, Mustafa Gülsün.
© 2022.
17 pages.
|
|
Yeşim Şener.
© 2022.
18 pages.
|
|
Salim Kurnaz, Deimantė Žilinskienė.
© 2022.
20 pages.
|
|
Dorothea Maria Bowyer, Walid El Hamad, Ciorstan Smark, Greg Evan Jones, Claire Beattie, Ying Deng.
© 2022.
29 pages.
|
|
Savas S. Ates, Vildan Durmaz.
© 2022.
24 pages.
|
|
Nusret Erceylan, Gaye Atilla.
© 2022.
20 pages.
|
|
|